Evidence indicated an increase of the transcription factor RUNX1 under pathological conditions such as myocardial infarction and dilated cardiomyopathy, suggesting its pivotal regulatory role (Li et al., 2019; Ni et al., 2021). This evidence concerns the gene RUNX1 and dilated cardiomyopathy.